SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹1,053,410 Cr | ₹10 Cr |
What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹1,053,410 Cr |
| Mar2017 | ₹10 Cr |
How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 26.12 | |
| Mar2024 | ₹20 Cr | 1.42 | |
| Mar2023 | ₹20 Cr | -100.00 | |
| Mar2022 | ₹1,053,410 Cr | 10,171,878.56 | |
| Mar2017 | ₹10 Cr | - | |
Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,377.1 Cr | -1% | -10.6% | -31% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.2% | 1.1% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | 0.7% | -2.9% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -1.6% | 13.6% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | 0.7% | -2.4% | 4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | 2.2% | 2.8% | 2.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1% |
-10.6% |
-31% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses